Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 07 12 2020
accepted: 21 01 2022
entrez: 2 3 2022
pubmed: 3 3 2022
medline: 13 4 2022
Statut: epublish

Résumé

The human hematopoietic stem cell harbors remarkable regenerative potential that can be harnessed therapeutically. During early development, hematopoietic stem cells in the fetal liver undergo active expansion while simultaneously retaining robust engraftment capacity, yet the underlying molecular program responsible for their efficient engraftment remains unclear. Here, we profile 26,407 fetal liver cells at both the transcriptional and protein level including ~7,000 highly enriched and functional fetal liver hematopoietic stem cells to establish a detailed molecular signature of engraftment potential. Integration of transcript and linked cell surface marker expression reveals a generalizable signature defining functional fetal liver hematopoietic stem cells and allows for the stratification of enrichment strategies with high translational potential. More precisely, our integrated analysis identifies CD201 (endothelial protein C receptor (EPCR), encoded by PROCR) as a marker that can specifically enrich for engraftment potential. This comprehensive, multi-modal profiling of engraftment capacity connects a critical biological function at a key developmental timepoint with its underlying molecular drivers. As such, it serves as a useful resource for the field and forms the basis for further biological exploration of strategies to retain the engraftment potential of hematopoietic stem cells ex vivo or induce this potential during in vitro hematopoietic stem cell generation.

Identifiants

pubmed: 35232959
doi: 10.1038/s41467-022-28616-x
pii: 10.1038/s41467-022-28616-x
pmc: PMC8888592
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1103

Informations de copyright

© 2022. The Author(s).

Références

Holt, P. G. & Jones, C. A. The development of the immune system during pregnancy and early life. Allergy 55, 688–697 (2000).
pubmed: 10955693 doi: 10.1034/j.1398-9995.2000.00118.x
Ciriza, J., Thompson, H., Petrosian, R., Manilay, J. O. & Garcia-Ojeda, M. E. The migration of hematopoietic progenitors from the fetal liver to the fetal bone marrow: lessons learned and possible clinical applications. Exp. Hematol. 41, 411–423 (2013).
pubmed: 23395775 doi: 10.1016/j.exphem.2013.01.009
Mikkola, H. K. & Orkin, S. H. The journey of developing hematopoietic stem cells. Development 133, 3733–3744 (2006).
pubmed: 16968814 doi: 10.1242/dev.02568
Palis, J. & Yoder, M. C. Yolk-sac hematopoiesis: the first blood cells of mouse and man. Exp. Hematol. 29, 927–936 (2001).
pubmed: 11495698 doi: 10.1016/S0301-472X(01)00669-5
McKinney-Freeman, S. et al. The transcriptional landscape of hematopoietic stem cell ontogeny. Cell Stem Cell 11, 701–714 (2012).
pubmed: 23122293 pmcid: 3545475 doi: 10.1016/j.stem.2012.07.018
Holyoake, T. L., Nicolini, F. E. & Eaves, C. J. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp. Hematol. 27, 1418–1427 (1999).
pubmed: 10480433 doi: 10.1016/S0301-472X(99)00078-8
Rodriguez-Fraticelli, A. E. et al. Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis. Nature 583, 585–589 (2020).
pubmed: 32669716 pmcid: 7579674 doi: 10.1038/s41586-020-2503-6
Walter, D. et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549–552 (2015).
pubmed: 25707806 doi: 10.1038/nature14131
Velten, L. et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nat. Cell Biol. 19, 271–281 (2017).
pubmed: 28319093 pmcid: 5496982 doi: 10.1038/ncb3493
Belluschi, S. et al. Myelo-lymphoid lineage restriction occurs in the human haematopoietic stem cell compartment before lymphoid-primed multipotent progenitors. Nat. Commun. 9, 4100 (2018).
pubmed: 30291229 pmcid: 6173731 doi: 10.1038/s41467-018-06442-4
Pellin, D. et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat. Commun. 10, 2395 (2019).
pubmed: 31160568 pmcid: 6546699 doi: 10.1038/s41467-019-10291-0
Weinreb, C., Rodriguez-Fraticelli, A., Camargo, F. D. & Klein, A. M. Lineage tracing on transcriptional landscapes links state to fate during differentiation. Science 367, eaaw3381 (2020).
Ranzoni, A. M. et al. Integrative single-cell RNA-seq and ATAC-seq analysis of human developmental hematopoiesis. Cell Stem Cell 28, 472–487 e477 (2021).
pubmed: 33352111 pmcid: 7939551 doi: 10.1016/j.stem.2020.11.015
Popescu, D. M. et al. Decoding human fetal liver haematopoiesis. Nature 574, 365–371 (2019).
pubmed: 31597962 pmcid: 6861135 doi: 10.1038/s41586-019-1652-y
Notta, F. et al. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333, 218–221 (2011).
pubmed: 21737740 doi: 10.1126/science.1201219
Sumide, K. et al. A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. Nat. Commun. 9, 2202 (2018).
pubmed: 29875383 pmcid: 5989201 doi: 10.1038/s41467-018-04441-z
Prashad, S. L. et al. GPI-80 defines self-renewal ability in hematopoietic stem cells during human development. Cell Stem Cell 16, 80–87 (2015).
pubmed: 25465114 doi: 10.1016/j.stem.2014.10.020
Subramaniam, A., Talkhoncheh, M. S., Magnusson, M. & Larsson, J. Endothelial protein C receptor (EPCR) expression marks human fetal liver hematopoietic stem cells. Haematologica 104, e47–e50 (2019).
pubmed: 30026339 pmcid: 6355479 doi: 10.3324/haematol.2018.198515
Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865–868 (2017).
pubmed: 28759029 pmcid: 5669064 doi: 10.1038/nmeth.4380
Laurenti, E. et al. CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell 16, 302–313 (2015).
pubmed: 25704240 pmcid: 4359055 doi: 10.1016/j.stem.2015.01.017
MacPherson, L. et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation. Nucleic Acids Res. 41, 1604–1621 (2013).
pubmed: 23275542 doi: 10.1093/nar/gks1337
Adelman, E. R. et al. Aging human hematopoietic stem cells manifest profound epigenetic reprogramming of enhancers that may predispose to leukemia. Cancer Disco. 9, 1080–1101 (2019).
doi: 10.1158/2159-8290.CD-18-1474
Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).
pubmed: 28991892 pmcid: 5937676 doi: 10.1038/nmeth.4463
Tsai, J. J. et al. Nrf2 regulates haematopoietic stem cell function. Nat. Cell Biol. 15, 309–316 (2013).
pubmed: 23434824 pmcid: 3699879 doi: 10.1038/ncb2699
Balazs, A. B., Fabian, A. J., Esmon, C. T. & Mulligan, R. C. Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 107, 2317–2321 (2006).
pubmed: 16304059 pmcid: 1895725 doi: 10.1182/blood-2005-06-2249
Fares, I. et al. EPCR expression marks UM171-expanded CD34( + ) cord blood stem cells. Blood 129, 3344–3351 (2017).
pubmed: 28408459 doi: 10.1182/blood-2016-11-750729
Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184–197 (2015).
pubmed: 26095251 pmcid: 4508757 doi: 10.1016/j.cell.2015.05.047
Taussig, D. C. et al. Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood 106, 4086–4092 (2005).
pubmed: 16131573 pmcid: 1895250 doi: 10.1182/blood-2005-03-1072
Hidalgo San Jose, L. et al. Modest declines in proteome quality impair hematopoietic stem cell self-renewal. Cell Rep. 30, 69–80 e66 (2020).
pubmed: 31914399 doi: 10.1016/j.celrep.2019.12.003
van Galen, P. et al. The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress. Nature 510, 268–272 (2014).
pubmed: 24776803 doi: 10.1038/nature13228
Kruta, M. et al. Hsf1 promotes hematopoietic stem cell fitness and proteostasis in response to ex vivo culture stress and aging. Cell Stem Cell 28, 1950–1965 e1956 (2021).
pubmed: 34388375 doi: 10.1016/j.stem.2021.07.009
Biswas, A. et al. The periostin/integrin-alphav axis regulates the size of hematopoietic stem cell pool in the fetal liver. Stem Cell Rep. 15, 340–357 (2020).
doi: 10.1016/j.stemcr.2020.06.022
Sigurdsson, V. et al. Bile acids protect expanding hematopoietic stem cells from unfolded protein stress in fetal liver. Cell Stem Cell 18, 522–532 (2016).
pubmed: 26831518 doi: 10.1016/j.stem.2016.01.002
Ahmed, S. et al. Loss of the mono-ADP-ribosyltransferase, tiparp, increases sensitivity to dioxin-induced steatohepatitis and lethality. J. Biol. Chem. 290, 16824–16840 (2015).
pubmed: 25975270 pmcid: 4505429 doi: 10.1074/jbc.M115.660100
Boitano, A. E. et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329, 1345–1348 (2010).
pubmed: 20688981 pmcid: 3033342 doi: 10.1126/science.1191536
Angelos, M. G. et al. Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells. Blood 129, 3428–3439 (2017).
pubmed: 28533309 pmcid: 5492090 doi: 10.1182/blood-2016-07-730440
Leung, A. et al. Notch and aryl hydrocarbon receptor signaling impact definitive hematopoiesis from human pluripotent. Stem Cells Stem Cells 36, 1004–1019 (2018).
pubmed: 29569827 doi: 10.1002/stem.2822
Grigoryan, A. et al. LaminA/C regulates epigenetic and chromatin architecture changes upon aging of hematopoietic stem cells. Genome Biol. 19, 189 (2018).
pubmed: 30404662 pmcid: 6223039 doi: 10.1186/s13059-018-1557-3
Zheng, S., Papalexi, E., Butler, A., Stephenson, W. & Satija, R. Molecular transitions in early progenitors during human cord blood hematopoiesis. Mol. Syst. Biol. 14, e8041 (2018).
pubmed: 29545397 pmcid: 5852373 doi: 10.15252/msb.20178041
van Galen, P. et al. Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion. Cell Stem Cell 14, 94–106 (2014).
pubmed: 24388174 doi: 10.1016/j.stem.2013.11.021
Zhang, G. et al. Bone morphogenetic protein signaling regulates Id1-mediated neural stem cell quiescence in the adult zebrafish brain via a phylogenetically conserved enhancer module. Stem Cells 38, 875–889 (2020).
Nguyen, T., Nioi, P. & Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291–13295 (2009).
pubmed: 19182219 pmcid: 2679427 doi: 10.1074/jbc.R900010200
Li, W. & Kong, A. N. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48, 91–104 (2009).
pubmed: 18618599 pmcid: 2631094 doi: 10.1002/mc.20465
Fidanza, A. et al. Single cell analyses and machine learning define hematopoietic progenitor and HSC-like cells derived from human PSCs. Blood 136, 2893–2904 (2020).
Hong, R. et al. Comprehensive generation, visualization, and reporting of quality control metrics for single-cell RNA sequencing data. Preprint at bioRxiv https://doi.org/10.1101/2020.11.16.385328 (2021).
Yang, S. et al. Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol. 21, 57 (2020).
pubmed: 32138770 pmcid: 7059395 doi: 10.1186/s13059-020-1950-6
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
pubmed: 27124452 pmcid: 4944528 doi: 10.1126/science.aad0501
Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278 (2015).
pubmed: 26653891 pmcid: 4676162 doi: 10.1186/s13059-015-0844-5
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 e1821 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381–386 (2014).
pubmed: 24658644 pmcid: 4122333 doi: 10.1038/nbt.2859
Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).
pubmed: 30914743 pmcid: 6435756 doi: 10.1038/s41598-019-41695-z
Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496–502 (2019).
pubmed: 30787437 pmcid: 6434952 doi: 10.1038/s41586-019-0969-x
Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979–982 (2017).
pubmed: 28825705 pmcid: 5764547 doi: 10.1038/nmeth.4402
McInnes, L., Healy, J., Melville, J. UMAP: Uniform manifold approximation and projection for dimension reduction. Preprint at arxiv https://arxiv.org/abs/1802.03426 (2018).
Suo, S. et al. Revealing the critical regulators of cell identity in the mouse cell atlas. Cell Rep. 25, 1436–1445 e1433 (2018).
pubmed: 30404000 pmcid: 6281296 doi: 10.1016/j.celrep.2018.10.045
Bilodeau, M., Shojaie, S., Ackerley, C., Post, M. & Rossant, J. Identification of a proximal progenitor population from murine fetal lungs with clonogenic and multilineage differentiation potential. Stem Cell Rep. 3, 634–649 (2014).
doi: 10.1016/j.stemcr.2014.07.010
Vanuytsel, K. et al Multi-modal profiling of human fetal liver hematopoietic stem cells reveals the molecular signature of engraftment. Github https://doi.org/10.5281/zenodo.5703879 (2021).

Auteurs

Kim Vanuytsel (K)

Section of Hematology and Medical Oncology, School of Medicine, Boston University, Boston, MA, USA. kimvan@bu.edu.
Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA. kimvan@bu.edu.

Carlos Villacorta-Martin (C)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Jonathan Lindstrom-Vautrin (J)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Zhe Wang (Z)

Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA.

Wilfredo F Garcia-Beltran (WF)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Vladimir Vrbanac (V)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Dylan Parsons (D)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Evan C Lam (EC)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

Taylor M Matte (TM)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Todd W Dowrey (TW)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Sara S Kumar (SS)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Mengze Li (M)

Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA.

Feiya Wang (F)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Anthony K Yeung (AK)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Gustavo Mostoslavsky (G)

Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA.

Ruben Dries (R)

Section of Hematology and Medical Oncology, School of Medicine, Boston University, Boston, MA, USA.
Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA.

Joshua D Campbell (JD)

Division of Computational Biomedicine, School of Medicine, Boston University, Boston, MA, USA.

Anna C Belkina (AC)

Department of Pathology and Laboratory Medicine, School of Medicine, Boston University, Boston, MA, USA.
Flow Cytometry Core Facility, School of Medicine, Boston University, Boston, MA, USA.

Alejandro B Balazs (AB)

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. abalazs@mgh.harvard.edu.

George J Murphy (GJ)

Section of Hematology and Medical Oncology, School of Medicine, Boston University, Boston, MA, USA. gjmurphy@bu.edu.
Center for Regenerative Medicine (CReM), Boston University and Boston Medical Center, Boston, MA, USA. gjmurphy@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH